| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 06/12/2013 | CN103153980A Derivatives of pyrazolophenyl-benzenesulfonamide compounds and use thereof as antitumor agents |
| 06/12/2013 | CN103153968A Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity |
| 06/12/2013 | CN103153965A Quinoxaline derivates |
| 06/12/2013 | CN103153963A Cyclopropane compound |
| 06/12/2013 | CN103153957A N-pyridin-3-yl or N-pyrazin-2-yl carboxamides |
| 06/12/2013 | CN103153955A Pyridine compounds and the uses thereof |
| 06/12/2013 | CN103153951A Pyrrolidinones as MetAP-2 inhibitors |
| 06/12/2013 | CN103145702A Aminopyrimidines useful as kinase inhibitors |
| 06/12/2013 | CN103145697A Nitrobenzimidazole compound, preparation method and application thereof |
| 06/12/2013 | CN103145620A Cb1 receptor modulators |
| 06/12/2013 | CN103145616A Novel nitrogen-containing heteroaryl compounds and methods of use thereof |
| 06/12/2013 | CN102382105B Bipolar host material used for blue emitting phosphor |
| 06/12/2013 | CN102267983B Sym-triazine derivative compounds containing sym-tetrazine rings and preparation method thereof |
| 06/12/2013 | CN102093339B Preparation method and application of pyrimidine derivatives |
| 06/12/2013 | CN101932562B Carbamoyl compounds as dgat1 inhibitors 190 |
| 06/12/2013 | CN101522664B Crystal modifications -3- (1h-ind0l-3-yl) -4- [2- (4-methyl-piperazin-1-yl) -quinazolin-4-yl] -pyrrole-2, 5-d ione |
| 06/12/2013 | CN101490040B 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial |
| 06/12/2013 | CN101208311B Pyrazine -2-carboxamide derivatives as mglur5 antagonists |
| 06/11/2013 | US8461351 Sterically bulky stabilizers |
| 06/11/2013 | US8461330 Imidazotriazines and imidazopyrimidines as kinase inhibitors |
| 06/11/2013 | US8461184 Sulphur containing pyrazole derivatives as selective cannabinoid CB1 receptor antagonists |
| 06/11/2013 | US8461160 Dihydropyrimidinones |
| 06/11/2013 | US8461147 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation |
| 06/11/2013 | CA2722102C Phenylpropionic acid derivative and use thereof |
| 06/11/2013 | CA2581516C Quinazoline derivatives |
| 06/11/2013 | CA2572218C Aryl-substituted benzimidazole and imidazopyridine ethers as anti-cancer agents |
| 06/11/2013 | CA2546101C N-acylsulfonamide apoptosis promoters |
| 06/11/2013 | CA2484209C Protein kinase modulators and methods of use |
| 06/11/2013 | CA2427334C Methods and compositions for the treatment of diseases of the eye |
| 06/06/2013 | WO2013082490A1 Substituted anilines as ccr(4) antagonists |
| 06/06/2013 | WO2013082429A1 Substituted benzimidazoles and benzopyrazoles as ccr(4) antagonists |
| 06/06/2013 | WO2013082338A1 Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (pmsa) and uses thereof |
| 06/06/2013 | WO2013081420A2 Phenoxypropanol derivative and pharmaceutical composition containing same |
| 06/06/2013 | WO2013081416A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 06/06/2013 | WO2013081088A1 Organic light emitting device and delayed fluorescent material and compound used therein |
| 06/06/2013 | WO2013079942A1 Catalyst compounds |
| 06/06/2013 | WO2013079578A1 Production of 18f- labelled compounds comprising hydrolytic deprotection step and solid phase extraction |
| 06/06/2013 | WO2013079505A1 Aminopyrimidine derivatives as lrrk2 modulators |
| 06/06/2013 | WO2013079495A1 2-(phenyl or pyrid-3-yl) aminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease |
| 06/06/2013 | WO2013079494A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease |
| 06/06/2013 | WO2013079460A1 Novel compounds |
| 06/06/2013 | WO2013079425A1 Novel 2h-indazoles as ep2 receptor antagonists |
| 06/06/2013 | WO2013079350A1 Insecticidal triazinone derivatives |
| 06/06/2013 | WO2013079223A1 Pyrrolo carboxamides as modulators of orphan nuclear receptor rar-related orphan receptor-gamma (rorϒ, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune diseases |
| 06/06/2013 | WO2013052699A3 Novel quinoxaline inhibitors of pi3k |
| 06/06/2013 | WO2012040108A3 Multivalent fluorescent probes |
| 06/06/2013 | US20130144059 Use of pdgf-r inhibitors for the treatment of lymph node metastasis of gastric cancer |
| 06/06/2013 | US20130144056 Human Adam-10 Inhibitors |
| 06/06/2013 | US20130144055 Benzene Sulfonamide Thiazole And Oxazole Compounds |
| 06/06/2013 | US20130143929 Fungicidal imidazoles |
| 06/06/2013 | US20130143893 Piperazine derivatives and methods of use |
| 06/06/2013 | US20130143892 New compounds, pharmaceutical compositions and uses thereof |
| 06/06/2013 | US20130143885 Chemical inducers of neurogenesis |
| 06/06/2013 | US20130143883 Modulators for amyloid beta |
| 06/06/2013 | US20130143880 Positive allosteric modulators of mglur2 |
| 06/06/2013 | US20130143871 4-aminoquinazolin-2-yl-1-pyrrazole-4-carboxylic acid compounds as prolyl hydroxylase inhibitors |
| 06/06/2013 | US20130143865 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 06/06/2013 | US20130143862 Certain amino-pyridazines, compositions thereof, and methods of their use |
| 06/06/2013 | US20130143860 Guanidine compound |
| 06/06/2013 | US20130142807 Compositions and methods for inhibition of the jak pathway |
| 06/06/2013 | DE112010005815T5 Bicarbazolverbindungen für OLEDs Bicarbazolverbindungen for OLEDs |
| 06/06/2013 | CA2856946A1 Pyrrolo carboxamides as modulators of orphan nuclear receptor rar-related orphan receptor-gamma (rory, nr1f3) activity and for the treatment of chronic inflammatory and autoimmunediseases |
| 06/06/2013 | CA2856839A1 Substituted anilines as ccr(4) antagonists |
| 06/06/2013 | CA2856831A1 Substituted benzimidazoles and benzopyrazoles as ccr(4) antagonists |
| 06/06/2013 | CA2856769A1 Novel 2h-indazoles as ep2 receptor antagonists |
| 06/06/2013 | CA2856457A1 Production of 18f- labelled compounds comprising hydrolytic deprotection step and solid phase extraction |
| 06/06/2013 | CA2856453A1 Insecticidal triazinone derivatives |
| 06/06/2013 | CA2850705A1 2- (phenyl or pyrid - 3 - yl) aminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease |
| 06/06/2013 | CA2850594A1 Aminopyrimidine derivatives as lrrk2 modulators |
| 06/06/2013 | CA2850593A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease |
| 06/05/2013 | EP2599386A1 2-aminopyrimidine modulators of the histamine h4 receptor |
| 06/05/2013 | EP2598498A1 Hetero-bicyclic derivatives as hcv inhibitors |
| 06/05/2013 | EP2598497A1 Cyclic amine azaheterocyclic carboxamides |
| 06/05/2013 | EP2598492A1 Bicyclic azaheterocyclic carboxamides as inhibitors of the kinase p70s6k |
| 06/05/2013 | EP2598491A1 Substituted 4-(4-fluoro-3-(piperazine-1- carbonyl)benzyl)phthalazin-1(2h)-one derivatives as poly (adp-ribose) polymerase- 1 inhibitors |
| 06/05/2013 | EP2598486A1 Bicyclic acetyl-coa carboxylase inhibitors |
| 06/05/2013 | EP2598149A2 Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases |
| 06/05/2013 | CN1978441B Phenylcarbazole-based compound and organic electroluminescent device employing the same |
| 06/05/2013 | CN103140484A Cyclic amine azaheterocyclic carboxamides |
| 06/05/2013 | CN103140478A Process for the synthesis of substituted urea compounds |
| 06/05/2013 | CN103137894A Light-emitting element, light-emitting device, electronic device, lighting device and organic compound |
| 06/05/2013 | CN103130796A 3-tertiary butyl pyrazole amides compounds and application thereof |
| 06/05/2013 | CN103130775A Indolinone derivatives serving as tyrosine kinase inhibitors |
| 06/05/2013 | CN103130774A Compound with tyrosine kinase inhibition effect and preparation method and application thereof |
| 06/05/2013 | CN103130723A Poly (aenosine diphosphate glucose pyrophospheralase (ADP)-ribose) polymerase inhibitor |
| 06/05/2013 | CN103127096A Application of pyrryl-substituted indole compound in curing glaucoma |
| 06/05/2013 | CN102321075B Preparation and bactericidal activity of 2-(1H-imidazole-1-yl)quinazoline derivatives |
| 06/05/2013 | CN102311426B Preparation method of olmesartan intermediate |
| 06/05/2013 | CN102134235B Preparation method of 2-oxo-1-pyrrolidine derivative |
| 06/05/2013 | CN102134234B Indazolyl urea compounds and preparation method and medicinal use thereof |
| 06/05/2013 | CN102088972B Pharmaceutical compositions containing imidazole-5-carboxylic acid derivatives and preparation method and use thereof |
| 06/05/2013 | CN102070619B Triazine derivative and preparation method and application thereof in plant antibacterial agent |
| 06/05/2013 | CN102046610B Phenyl piperazine compounds, pharmaceutical composition including the same, and use thereof |
| 06/05/2013 | CN101918391B Some 2-pyrazinone derivatives and their use in preparing inhibitors of neutrophile elastase |
| 06/05/2013 | CN101842361B Pyrazinone derivatives and their use in the treatment of lung diseases |
| 06/05/2013 | CN101679363B Novel pyrimidine compound having benzyl(heterocyclicmethyl)amine structure and pharmaceutical product containing the same |
| 06/05/2013 | CN101619043B Quinazoline derivant and medical application thereof |
| 06/05/2013 | CN101328319B Water-soluble bridged ring polymethine 3H-indole cyanine dyes ultrasonic synthetic method |
| 06/04/2013 | US8455866 Heterocyclic compound and organic light-emitting device including the same |
| 06/04/2013 | US8455662 Formulations for benzimidazolyl pyridyl ethers |